Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

TURNOVER (x1000 SEK)

NET PROFIT (x1000 SEK)

Share

RPH Pharmaceuticals AB

Closing information (x1000 SEK)

Closing information 2024/12 2023/12 2022/12
Turnover 432,242 Less Arrow 329,395 Less Arrow 230,801
Financial expenses 30,417 More Arrow 32,078 Less Arrow 17,903
Earnings before taxes 127,876 Less Arrow 44,425 Less Arrow 37,196
EBITDA 133,252 Less Arrow 109,303 Less Arrow 74,522
Total assets 258,968 More Arrow 320,128 Less Arrow 300,680
Current assets 73,866 More Arrow 108,288 Less Arrow 94,723
Current liabilities 203,718 More Arrow 278,738 Less Arrow 255,287
Equity capital 52,328 Less Arrow 38,468 More Arrow 42,471
- share capital 100 Equal arrow 100 Equal arrow 100
Employees (average) 0 Equal arrow 0 Equal arrow 0

Financial ratios

Fiscal year 2024/12 2023/12 2022/12
Solvency 20.2% Less Arrow 12.0% More Arrow 14.1%
Turnover per employee
Profit as a percentage of turnover 29.6% Less Arrow 13.5% More Arrow 16.1%
Return on assets (ROA) 61.1% Less Arrow 23.9% Less Arrow 18.3%
Current ratio 36.3% More Arrow 38.8% Less Arrow 37.1%
Return on equity (ROE) 244.4% Less Arrow 115.5% Less Arrow 87.6%
Change turnover 102,847 Less Arrow 98,594 Less Arrow 50,994
Change turnover % 31% More Arrow 43% Less Arrow 28%
Chg. No. of employees 0 Equal arrow 0 Equal arrow 0
Chg. No. of employees %

Total value of public sale

Fiscal year 2024/12 2023/12 2022/12
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.